| Title: |
Pembrolizumab in relapsed or refractory Hodgkin lymphoma: a post hoc analysis of KEYNOTE-204 by prior lines of therapy |
| Authors: |
Kuruvilla, John; Modi, Dipenkumar; Santoro, Armando; Paszkiewicz-Kozik, Ewa; Gasiorowski, Robin; Johnson, Nathalie A.; Fogliatto, Laura Maria; Gonçalves, Iara; de Oliveira, Jose; Buccheri, Valeria; Perini, Guilherme Fleury; Goldschmidt, Neta; Kriachok, Iryna; Sekiguchi, Naohiro; Lin, Jianxin; Yusuf, Rushdia; Marinello, Patricia; Zinzani, Pier Luigi |
| Contributors: |
Merck Sharp and Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA |
| Source: |
Leukemia & Lymphoma ; volume 66, issue 9, page 1710-1719 ; ISSN 1042-8194 1029-2403 |
| Publisher Information: |
Informa UK Limited |
| Publication Year: |
2025 |
| Document Type: |
article in journal/newspaper |
| Language: |
English |
| DOI: |
10.1080/10428194.2025.2502805 |
| Availability: |
https://doi.org/10.1080/10428194.2025.2502805; https://www.tandfonline.com/doi/pdf/10.1080/10428194.2025.2502805 |
| Rights: |
http://creativecommons.org/licenses/by/4.0/ |
| Accession Number: |
edsbas.7182A52F |
| Database: |
BASE |